Abstract
Breast cancer is the most common cancer suffered by female, and the second highest cause of cancer-related death among women worldwide. At present, hormone therapy is still the main treatment route and can be divided into three main categories: selective estrogen receptor modulators (SERMs), selective estrogen receptor downregulators (SERDs), and aromatase inhibitors (AIs). However, breast cancer is difficult to cure even after several rounds of anti-estrogen therapy and most drugs have serious side-effects. Here, we review the literature published over the past five years regarding the isolation and synthesis of analogs and their derivatives.
| Original language | English |
|---|---|
| Pages (from-to) | 1318-1337 |
| Number of pages | 20 |
| Journal | Current Topics in Medicinal Chemistry |
| Volume | 19 |
| Issue number | 15 |
| DOIs | |
| Publication status | Published - 1 Jan 2019 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Analogs
- Bioactivity
- Breast cancer
- Derivatives
- Estrogen receptor α
- Structure-activity relationship.
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver